Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)

Zhou, Hai-Yu; Zheng, Shao-Peng; Li, An-Lin; Gao, Quan-Long; Ou, Qi-Yun; Chen, Yong-Jian; Wu, Shao-Tao; Lin, Da-Gui; Liu, Sheng-Bo; Huang, Lu-Yu; Li, Fa-Sheng; Zhu, Hong-Yuan; Qiao, Gui-Bin; Lanuti, Michael; Yao, He-Rui; Yu, Yun-Fang

Published in

Elsevier, EClinicalMedicine, (24), p. 100422, 2020

DOI: 10.1016/j.eclinm.2020.100422

Tools

Export citation

Search in Google Scholar

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)

Journal article published in 2020 by Hai-Yu Zhou, Shao-Peng Zheng, An-Lin Li, Quan-Long Gao, Qi-Yun Ou, Yong-Jian Chen, Shao-Tao Wu, Da-Gui Lin, Sheng-Bo Liu

, Lu-Yu Huang

, Fa-Sheng Li, Hong-Yuan Zhu, Gui-Bin Qiao, Michael Lanuti, He-Rui Yao

and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)